For both astrocytes and C6 glioma cells, S100B is constitutively secreted and can, in situations of injury, be more actively released, acting as an alarmin on RAGE, the receptor for both glycation end-products and S100B itself [7]. The gene discussed is S100B; the disease is central nervous system cancer.